))
Episode #46 - Pioneering Cannabis Bioharmaceuticals with Cannovation Clinical Research Partners, LLC. Lisa Rich Milan and Michael Zaccaria
Manage episode 432101083 series 3450262
Content provided by Roots to Risk Podcast With Eric Schneider & Isaac Bock, Roots to Risk Podcast With Eric Schneider, and Isaac Bock. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roots to Risk Podcast With Eric Schneider & Isaac Bock, Roots to Risk Podcast With Eric Schneider, and Isaac Bock or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this insightful episode of Roots to Risk, hosts Eric Schneider and Isaac Bock welcome back Lisa Rich Milan, alongside her co-founder Michael Zaccaria, to delve into their groundbreaking new venture, Cannovation Clinical Research Partners, LLC.
Shifting from the traditional CPG discussions, this episode explores the innovative biotech and pharmaceutical approaches to cannabis. Lisa and Michael share their vision of expediting drug discovery and bringing cannabis-related medical products to market, shedding light on regulatory challenges, the impact of rescheduling cannabis to a Schedule III substance, and the promising future of cannabis in the pharmaceutical landscape.
Tune in to learn about the intersection of cannabis, biotech, and the potential for significant advancements in medical treatments.
48 episodes
Share
